On today’s show, hosts April Glaser and Will Oremus discuss the ongoing fallout at Facebook over the company’s decision to hire a conservative PR firm to surface opposition research in order to attack Facebook’s nonprofit critics by highlighting their funding ties to the liberal financier George Soros, playing into an untrue and anti-Semitic popular right wing trope. As internal and external turmoil continues to rile major American technology companies, their employee are organizing for serious change. Hosts dig into what that’s accomplished so far and what continued employee pressure and mounting labor actions means down the line.
Then, an interview with Antonio Regalado, a senior editor at the MIT Technology Review, on a story he broke Sunday night: the very first gene-edited babies were born this month in China. The trio discuss the history of gene-editing technology and the debate about using it on humans. To some, gene-editing is a form of medicine, like a vaccination. To others, it’s a form of enhancement. How easy is this to do? And will we have a future where the health of tomorrow’s children, or those whose parents can afford it, will be determined before their children are even born?
14:13 - Interview with Antonio Regalado32:02 - Don’t Close My Tabs
Don’t Close My Tabs:
The New Yorker: Exploding Mojitos: The First “Sonic Attacks” Targeting American Diplomats in Cuba May Have Taken Place Thirty Years Ago
The New York Times: A Business with No End
Podcast production by Max Jacobs
If Then plugs:
You can get updates about what’s coming up next by following us on Twitter @ifthenpod. You can follow Will @WillOremus and April @Aprilaser. If you have a question or comment, you can email us at firstname.lastname@example.org.
If Then is presented by Slate and Future Tense, a collaboration among Arizona State University, New America, and Slate. Future Tense explores the ways emerging technologies affect society, policy, and culture. To read more, follow us on Twitter and sign up for our weekly newsletter.
Listen to If Then via Apple Podcasts, Overcast, Spotify, Stitcher, or Google Play.